BME100 f2015:Group15 1030amL2

BME 100 Fall 2015	Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
OUR TEAM Name: Paige Williams Name: Sydney Spicer Name: Esteban Medrano Name: Elijah Olivas Name: Vishal Giri Name: Tofi Lautoa LAB 2 WRITE-UP Descriptive Statistics Human trials Averages 0mg 3.834 5mg 8.932 10mg 61.622 15mg 657.941 Standard Deviation 0mg 1.523010177 5mg 1.593931547 10mg 30.11069386 15mg 212.9429762 Count 0mg 10 5mg 10 10mg 10 15mg 10 Standard Error 0mg 0.481618106 5mg 0.504045412 10mg 9.521837451 15mg 67.33848166 Median 0mg 4.12 5mg 8.98 10mg 73.395 15mg 722.505 Rat trials Averages 0 milligrams: 10.516 10 milligrams: 11.112 Standard Deviations 0 milligrams: 2.225551617 (units?) 10 milligrams: 7.402885924 (units?) Standard Errors 0 milligrams: 0.99529694 (units?) 10 milligrams: 3.310671231 (units?) Results Experiment 1 ‎Rat Trials Note: Error bars use standard deviation of data in this data set. Experiment 2 Human Trials Analysis Experiment 1 As seen in the data graphed above, as the dosage of LPS was increased from 0mg, 5mg, 10mg, and 15mg, the inflammotin levels in the blood of the rat rose consistently. When the data was put through an ANOVA test all of the data was found to be significant. Experiment 2 When different groups of human subjects were given 0mg, 5mg, 10mg, and 15mg of LPS, the levels of inflammotin were then recorded. When this data was graphed it could be seen that as the dosage of LPS was raised, the inflammotin levels in the subjects rose as well. Before being graphed, the data was put through an ANOVA test and all of the data was found to be significant. The demonstrated error bars can be seen on the bar graph above and were calculated from the standard deviation of the data. Summary/Discussion To answer the question of how LPS dosages affect inflammotin levels in the body, groups of rat and human test subjects were chosen by strict criteria so as to prevent sample bias as much as possible. Each dosage of LPS, 0mg, 5mg, 10mg, and 15mg, were each given to a different group of subjects. The inflammotin levels were then recorded and the data clearly shows that in both the rat and human test subjects, as the dosage of LPS was increased, the levels of inflammotin in the subjects increased. Both sets of data were put through ANOVA tests because the data was dealing with more than two test groups, and all of the data was found to be significant.